We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$112M
1-Year Est. Return
48.41%
This Fund
S&P 500
This Quarter
Est. Return
+1.8%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$4.85B
AUM Growth
-$566M
(-10%)
Cap. Flow
-$45.3M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
63.37%
Holding
40
New
8
Increased
9
Reduced
10
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$178M |
| 2 |
OPTU
Optimum Communications Inc
OPTU
|
+$120M |
| 3 |
Vistra
VST
|
+$99.9M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$69.9M |
| 5 |
Conduent
CNDT
|
+$65.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$208M |
| 2 |
JD.com
JD
|
+$168M |
| 3 |
Williams Companies
WMB
|
+$141M |
| 4 |
Southwest Gas
SWX
|
+$82.7M |
| 5 |
Johnson Controls International
JCI
|
+$69.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.76% |
| 2 | Communication Services | 16.64% |
| 3 | Real Estate | 15.01% |
| 4 | Industrials | 14.18% |
| 5 | Technology | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCE.A
1
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $570M | 11.76% |
23,585,735
-84,536
| -0.4% | -$1.95M |
|
|
SPR
2
DELISTED
Spirit AeroSystems
SPR
| $432M | 8.92% |
7,460,682
+855,390
| +13% | +$48M |
|
3
Netflix
NFLX
$326B
| $380M | 7.84% |
25,444,600
-109,780
| -0.4% | -$1.69M |
|
4
Itron
ITRI
$4.03B
| $309M | 6.37% |
4,558,387
| – | – |
|
5
Baidu
BIDU
$31B
| $292M | 6.02% |
1,631,838
-144,369
| -8% | -$26.2M |
|
|
6
Johnson Controls International
JCI
$83.5B
| $255M | 5.27% |
5,887,736
-1,668,781
| -22% | -$69.9M |
|
|
GWPH
7
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $250M | 5.16% |
2,494,738
+506,421
| +25% | +$54.5M |
|
|
8
JD.com
JD
$36.7B
| $244M | 5.04% |
6,225,674
-4,440,935
| -42% | -$168M |
|
|
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $182M | 3.75% |
15,308,143
+5,621,881
| +58% | +$69.9M |
|
|
SRC
10
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $158M | 3.26% |
+4,750,226
| New | +$178M |
|
|
TMH
11
DELISTED
Team Health Holdings Inc
TMH
| $145M | 3% |
3,338,649
| – | – |
|
|
ACOR
12
DELISTED
Acorda Therapeutics
ACOR
| $142M | 2.94% |
60,199
+13,796
| +30% | +$27.3M |
|
13
CONMED
CNMD
$1.4B
| $141M | 2.91% |
2,774,045
| – | – |
|
|
NDRM
14
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $131M | 2.7% |
4,383,358
| – | – |
|
15
Fidelity National Financial
FNF
$11.7B
| $130M | 2.68% |
4,173,128
-467,002
| -10% | -$13.5M |
|
|
OPTU
16
Optimum Communications Inc
OPTU
$375M
| $117M | 2.42% |
+3,629,740
| New | +$120M |
|
17
Travere Therapeutics
TVTX
$5.8B
| $116M | 2.39% |
5,973,111
+89,455
| +2% | +$1.62M |
|
|
18
Conduent
CNDT
$257M
| $111M | 2.29% |
6,979,221
+4,018,064
| +136% | +$65.8M |
|
|
19
Vistra
VST
$47.7B
| $106M | 2.19% |
+6,324,010
| New | +$99.9M |
|
20
Antero Resources
AR
$12.1B
| $100M | 2.07% |
4,643,955
+1,250,872
| +37% | +$26.8M |
|
21
CNX Resources
CNX
$5.28B
| $95M | 1.96% |
7,631,874
+1,052,974
| +16% | +$13.6M |
|
|
22
United Therapeutics
UTHR
$21.5B
| $91.5M | 1.89% |
705,003
-1,668,184
| -70% | -$208M |
|
23
Ligand Pharmaceuticals
LGND
$5.41B
| $88.4M | 1.82% |
1,167,886
-697,737
| -37% | -$48.8M |
|
24
Targa Resources
TRGP
$61.5B
| $87.3M | 1.8% |
1,930,592
+462,267
| +31% | +$23.3M |
|
|
25
CALL
Baidu
BIDU
$31B
| $71.5M | 1.48% |
+400,000
| New | +$72.5M |
|
Similar funds
SWM
TFS
WAM
CS
BU
TBFA
VDC
RQS
Scopia Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Scopia Capital Management held 40 positions worth $4.85B, down 10% from $5.41B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Scopia Capital Management's Q2 2017 filing shows 8 new, 9 increased, 10 reduced and 5 closed positions. Its largest new stake was SPIRIT REALTY CAPITAL, INC.: 4,750,226 shares worth $158M. The largest sale was United Therapeutics, an estimated $208M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Communication Services and Real Estate.
- Scopia Capital Management's largest Q2 2017 buy was SPIRIT REALTY CAPITAL, INC.: 4,750,226 shares worth $158M.
- Scopia Capital Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017, an estimated $69.9M increase.
- Scopia Capital Management's biggest Q2 2017 reduction was United Therapeutics, cutting an estimated $208M.
- Scopia Capital Management fully exited Williams Companies in Q2 2017, selling an estimated $141M.
- Scopia Capital Management's ten largest holdings make up 63% of its $4.85B portfolio in Q2 2017.
- Scopia Capital Management opened 8 new positions and closed 5 in Q2 2017.
- Scopia Capital Management's portfolio value fell 10% quarter-over-quarter to $4.85B.
Based on Scopia Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.